Envigo Pharma Consulting Limited   Report issue

For profit Phase 1 Phase 2
Founded: Huntingdon United Kingdom (2015)

Organization Overview

First Clinical Trial
2016
NCT02861586
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2016

Timeline

NOW
  • Now

Alternative names

Envigo

Active Ingredients

Drugs in Phase 2 Trials (3)

mv-chik (1 trial)

priorix (1 trial)

sodium chloride (1 trial)

Drugs in Phase 1 Trials (1)

testosterone (delatestryl) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Chikungunya Fever (Phase 2)

Hypogonadism (Phase 1)

Virus Diseases (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 2
  • # of Trial APIs: 4